China Bio-immunity Corporation (HBB) Earnings
|
Expand Research on HBB
| Next EPS Date | 5/1/24 | EPS Growth Rate | -100.0% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | +33.3% | Revenue Growth Rate | -100.0% *Last Qtr. |
| Average % Move 1-Wk after EPS | +11.6% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 5/1/24 | Q124 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 3/6/24 | Q423 | $1.40 | $0.81 | +$0.59 | $206.7M | $199.7M | N/A |  | | Details | |
| 11/1/23 | Q323 | $0.74 | $0.31 | +$0.43 | $153.6M | $153.1M | N/A | | | Details | |
| 8/2/23 | Q223 | $0.01 | $0.22 | -$0.21 | $137.1M | $144.1M | N/A | | | Details | |
| 5/3/23 | Q123 | $0.34 | $0.29 | +$0.05 | $128.3M | $144.1M | N/A | | | Details | |
| 3/8/23 | Q422 | N/A | $0.97 | N/A | N/A | $213.3M | N/A | N/A | N/A | ||
| 11/2/22 | Q322 | $0.43 | $0.37 | +$0.06 | $150.8M | $157.8M | N/A | | | Details | |
| 8/3/22 | Q222 | $0.36 | $0.22 | +$0.14 | $147.5M | $150.7M | N/A | | | Details |
